Skip to main content
. 2019 Feb 13;36(3):608–620. doi: 10.1007/s12325-019-0879-1

Table 3.

Summary of statin use at the first visit of the observation period

Statin Dose (mg) Patients (%)
Atorvastatin 5–10 98 (7.9%)
20–30 219 (17.7%)
40–80 311 (25%)
Rosuvastatin 5 23 (1.9%)
10–15 195 (15.7%)
20–40 194 (15.6%)
Simvastatin 5–40 86 (6.9%)
Fluvastatin 40–80 8 (0.6%)
Pravastatin 10–40 8 (0.6%)
Lovastatin 10–40 3 (0.2%)
Unknown/not taking statins 99 (8.0%)
Total 1244 (100%)